Page last updated: 2024-08-22

misonidazole and Bone Cancer

misonidazole has been researched along with Bone Cancer in 6 studies

Research

Studies (6)

TimeframeStudies, this research(%)All Research%
pre-19904 (66.67)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's2 (33.33)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Ametamey, SM; Arlt, MJ; Born, W; Brennecke, P; Campanile, C; Fischer, CR; Fuchs, B; Gvozdenovic, A; Honer, M; Krämer, SD; Müller, A; Sabile, AA; Schibli, R1
Bradley, KM; Fenwick, JD; Gleeson, FV; Higgins, GS; Macpherson, RE; McGowan, DR1
Brustad, T; Rofstad, EK1
Bataini, JP; Bernier, J; Brugère, J; Brunin, F; de Narbonne, J; Jaulerry, C1
Grierson, JR; Grunbaum, Z; Koh, WJ; Krohn, KA; Rasey, JS1
Glatstein, E; Kinsella, TJ1

Trials

1 trial(s) available for misonidazole and Bone Cancer

ArticleYear
[Clinical testing of the radiosensitizer RO-07-0582 (misonidazole). Dose tolerance, toxicity and pharmacokinetic studies, preliminary report (author's transl)].
    Bulletin du cancer, 1978, Volume: 65, Issue:4

    Topics: Bone Neoplasms; Clinical Trials as Topic; Glioma; Humans; Kinetics; Misonidazole; Neoplasms; Nitroimidazoles; Otorhinolaryngologic Diseases; Sarcoma

1978

Other Studies

5 other study(ies) available for misonidazole and Bone Cancer

ArticleYear
Characterization of different osteosarcoma phenotypes by PET imaging in preclinical animal models.
    Journal of nuclear medicine : official publication, Society of Nuclear Medicine, 2013, Volume: 54, Issue:8

    Topics: Animals; Bone Neoplasms; Cell Line, Tumor; Disease Models, Animal; Drug Resistance, Neoplasm; Female; Fluorides; Fluorodeoxyglucose F18; Humans; Mice; Misonidazole; Osteoblasts; Osteoclasts; Osteosarcoma; Phenotype; Positron-Emission Tomography; Tibia

2013
18F-Misonidazole PET-CT scan detection of occult bone metastasis.
    Thorax, 2016, Volume: 71, Issue:1

    Topics: Aged; Bone Neoplasms; Carcinoma, Non-Small-Cell Lung; Combined Modality Therapy; Diagnosis, Differential; Humans; Lung Neoplasms; Male; Misonidazole; Multimodal Imaging; Positron-Emission Tomography; Radiopharmaceuticals; Tomography, X-Ray Computed

2016
Radiosensitizing effect of misonidazole in acute and fractionated irradiation of a human osteosarcoma xenograft.
    International journal of radiation oncology, biology, physics, 1980, Volume: 6, Issue:9

    Topics: Adolescent; Animals; Bone Neoplasms; Dose-Response Relationship, Radiation; Humans; Male; Mice; Mice, Nude; Misonidazole; Neoplasm Transplantation; Nitroimidazoles; Osteosarcoma; Transplantation, Heterologous

1980
Radiolabelled fluoromisonidazole as an imaging agent for tumor hypoxia.
    International journal of radiation oncology, biology, physics, 1989, Volume: 17, Issue:5

    Topics: Adenocarcinoma; Animals; Bone Neoplasms; Cell Hypoxia; Cells, Cultured; Contrast Media; Cricetinae; Cricetulus; Dogs; Fibroblasts; Mammary Neoplasms, Experimental; Mice; Mice, Inbred BALB C; Mice, Inbred C3H; Misonidazole; Osteosarcoma; Radiation Tolerance; Radionuclide Imaging; Sarcoma, Experimental

1989
Clinical experience with intravenous radiosensitizers in unresectable sarcomas.
    Cancer, 1987, Mar-01, Volume: 59, Issue:5

    Topics: Adolescent; Adult; Aged; Bone and Bones; Bone Neoplasms; Bromodeoxyuridine; Female; Humans; Injections, Intravenous; Male; Middle Aged; Misonidazole; Radiation Dosage; Radiation-Sensitizing Agents; Sarcoma

1987